Prevention and treatment of cancer-related infections

Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R. Dubberke, Alison G. Freifeld, Ramiro Garzon, John N. Greene, John P. Greer, James I. Ito, Judith E. Karp, Daniel R. Kaul, Earl King, Emily Mackler, Kieren A. Marr, Jose G. Montoya, Ashley Morris-Engemann, Peter G. Pappas, Ken Rolston, Brahm SegalSusan K. Seo, Sankar Swaminathan, Maoko Naganuma, Dorothy A. Shead

Research output: Contribution to journalReview articlepeer-review

155 Scopus citations

Abstract

Patients with cancer are at increased risk for developing infectious complications during the course of their disease and treatment. The following sections of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prevention and Treatment of Cancer-Related Infections provide an overview of the risk factors for infectious complications, recommendations for infectious risk categorization, and strategies for prevention of infections in high-risk patient populations with cancer. Individualized risk evaluation for infections and incorporation of preventative measures are essential components of the overall spectrum of cancer care, and may contribute to optimizing treatment outcomes for patients.

Original languageEnglish (US)
Pages (from-to)1412-1445
Number of pages34
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number11
DOIs
StatePublished - Nov 1 2012

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Prevention and treatment of cancer-related infections'. Together they form a unique fingerprint.

Cite this